Purchases and Sales Made in Q3 2022 in Evelo Biosciences, Inc. (EVLO)
This table provides information about the institutional ownership of Evelo Biosciences, Inc. (EVLO) during Q3 2022. The information is specifically focused on institutions that hold shares of Evelo Biosciences, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
1.86M+ 136.89% |
$3.46M - $77.8M
|
3.22M
$0
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
294K+ 32.32% |
$548K - $12.3M
|
1.21M
$0
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
240K+ 69.15% |
$446K - $10M
|
586K
$0
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
105KNew |
$196K - $4.4M
|
105K
$0
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
23.1K+ 32.07% |
$43K - $967K
|
95.3K
$0
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
20.5K+ 72.47% |
$38.1K - $855K
|
48.7K
$0
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
19.7K+ 20.92% |
$36.6K - $823K
|
114K
$0
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
18KNew |
$33.4K - $751K
|
18K
$0
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
- |
4.21K+ 217.81% |
$7.83K - $176K
|
6.14K
$0
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
3KNew |
$5.58K - $125K
|
3K
$0
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
2.61KNew |
$4.86K - $109K
|
2.61K
$0
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2.14K+ 42.28% |
$3.98K - $89.5K
|
7.21K
$0
|
|
Oct 07, 2024
Q3 2022
|
Fairfield Financial Advisors, LTD
Wellesley, MA |
BUY
|
- |
1.08KNew |
$2K - $44.9K
|
1.08K
$0
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.01KNew |
$1.88K - $42.3K
|
1.01K
$0
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
197+ 107.65% |
$366 - $8.23K
|
380
$0
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
144New |
$268 - $6.02K
|
144
$0
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-200- 1.04% |
$372 - $8.36K
|
19.1K
$0
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-667- 11.21% |
$1.24K - $27.9K
|
5.29K
$0
|
|
Nov 14, 2022
Q3 2022
|
Cresset Asset Management, LLC
Chicago, IL |
SELL
|
- |
-1.63K- 8.17% |
$3.04K - $68.3K
|
18.4K
$0
|
|
Nov 10, 2022
Q3 2022
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-4.55K- 0.12% |
$8.46K - $190K
|
3.67M
$0
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-7.97K- 18.97% |
$14.8K - $333K
|
34.1K
$0
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-7.97K- 18.97% |
$14.8K - $333K
|
34.1K
$0
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-8.47K- 4.39% |
$15.8K - $354K
|
185K
$0
|
|
Nov 14, 2022
Q3 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-11.1K- 36.03% |
$20.6K - $463K
|
19.7K
$0
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-11.8K- 51.48% |
$21.9K - $491K
|
11.1K
$0
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-13.1KClosed |
$24.3K - $547K
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-75.2K- 53.91% |
$140K - $3.14M
|
64.3K
$0
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-87.9K- 73.72% |
$164K - $3.68M
|
31.3K
$0
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-277K- 90.99% |
$515K - $11.6M
|
27.4K
$0
|
|
Nov 14, 2022
Q3 2022
|
Cvi Holdings, LLC
Wilmington, DE |
SELL
|
- |
-361K- 17.58% |
$672K - $15.1M
|
1.69M
$0
|